 Dysfunction in endogenous pain inhibitory systems has been proposed as a factor in the development and maintenance clinical pain disorders particularly in Temporomandibular Disorder TMD. Dysfunction has been observed with a model known as diffuse noxious inhibitory controls DNIC, but other models that engage inhibitory systems offset analgesia have not been fully evaluated in chronic pain patients. 